139 related articles for article (PubMed ID: 23237390)
21. The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.
Grabczewska Z; Białoszyński T; Szymański P; Sukiennik A; Swiatkiewicz I; Koziński M; Kochman W; Grześk G; Kubica J
Cardiol J; 2008; 15(4):344-50. PubMed ID: 18698543
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina--the VASCO-angina study.
Vitale C; Spoletini I; Malorni W; Perrone-Filardi P; Volterrani M; Rosano GM
Int J Cardiol; 2013 Sep; 168(2):1078-81. PubMed ID: 23200272
[TBL] [Abstract][Full Text] [Related]
23. Trimetazidine in geriatric patients with stable angina pectoris: the tiger study.
Kölbel F; Bada V
Int J Clin Pract; 2003 Dec; 57(10):867-70. PubMed ID: 14712887
[TBL] [Abstract][Full Text] [Related]
24. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
25. Trimetazidine Modified Release in the Treatment of Stable Angina : TRIUMPH StudyTRImetazidine MR in Patients with Stable Angina: Unique Metabolic PatH.
Makolkin VI; Osadchiy KK
Clin Drug Investig; 2004; 24(12):731-8. PubMed ID: 17523736
[TBL] [Abstract][Full Text] [Related]
26. Oral nicorandil reduces ischemic attacks in patients with stable angina: A prospective, multicenter, open-label, randomized, controlled study.
Jiang J; Li Y; Zhou Y; Li X; Li H; Tang B; Dai X; Ma T; Li L; Huo Y
Int J Cardiol; 2016 Dec; 224():183-187. PubMed ID: 27657471
[TBL] [Abstract][Full Text] [Related]
27. Trimetazidine in Practice: Review of the Clinical and Experimental Evidence.
Dézsi CA
Am J Ther; 2016; 23(3):e871-9. PubMed ID: 25756467
[TBL] [Abstract][Full Text] [Related]
28. Trimetazidine in angina and poor muscle function: protocol for a randomized controlled study.
Zhang YJ; Wang JX; Fu SH; Li XY
Chin Med J (Engl); 2019 Jun; 132(12):1461-1466. PubMed ID: 31205105
[TBL] [Abstract][Full Text] [Related]
29. Trimetazidine added to combined hemodynamic antianginal therapy in patients with type 2 diabetes: a randomized crossover trial.
Ribeiro LW; Ribeiro JP; Stein R; Leitão C; Polanczyk CA
Am Heart J; 2007 Jul; 154(1):78.e1-7. PubMed ID: 17584555
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of Long-acting Trimetazidine in Different Clinical Situations in Patients with Stable Angina Pectoris: Findings from ODA Trial.
Glezer MG; Vygodin VA;
Cardiol Ther; 2019 Jun; 8(1):69-78. PubMed ID: 30778909
[TBL] [Abstract][Full Text] [Related]
31. [Trimetazidine in pectoris patients older than 65 years with stable angina].
Syrkin AL; Lepakhin VK; Fitilev SB; Ivanova EV; Titarova IuIu; Levin AM
Kardiologiia; 2002; 42(6):24-31. PubMed ID: 12494126
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials.
Peng S; Zhao M; Wan J; Fang Q; Fang D; Li K
Int J Cardiol; 2014 Dec; 177(3):780-5. PubMed ID: 25466565
[TBL] [Abstract][Full Text] [Related]
33. Food effect on bioavailability of modified-release trimetazidine tablets.
Ozbay L; Unal DO; Erol D
J Clin Pharmacol; 2012 Oct; 52(10):1535-9. PubMed ID: 22162540
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of Patients With Stable Ischemic Heart Disease in Real Clinical Practice in Russia. The CHOICE-2 Program].
Glezer M G; On Behalf Of The Choice-Study Participants OB
Kardiologiia; 2016 May; 56(5):5-11. PubMed ID: 28294866
[TBL] [Abstract][Full Text] [Related]
35. Effect of nitrate withdrawal on quality of life and adherence to treatment in patients with stable angina: evidence from a randomized clinical trial.
Lemos KF; Rabelo-Silva ER; Ribeiro LW; Cruz LN; Polanczyk CA
Coron Artery Dis; 2014 May; 25(3):215-23. PubMed ID: 24553094
[TBL] [Abstract][Full Text] [Related]
36. Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis.
Belsey J; Savelieva I; Mugelli A; Camm AJ
Eur J Prev Cardiol; 2015 Jul; 22(7):837-48. PubMed ID: 24776376
[TBL] [Abstract][Full Text] [Related]
37. [Antiischemic efficacy of trimetazidine in patients with ischemic heart disease, stable angina pectoris and disturbances of carbohydrate metabolism].
Fedotkina IuA; Panchenko EP
Kardiologiia; 2002; 42(2):28-33. PubMed ID: 12494204
[TBL] [Abstract][Full Text] [Related]
38. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
Belardinelli R
Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the effectiveness of risk minimization measures for trimetazidine: A cross sectional joint PASS survey among physicians in selected European countries.
von Bredow D; Toussi M; Samad A; Kaplan S; Domahidy M; de Voogd H; Böhmert S; Ramos RS; Arora D
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1385-1392. PubMed ID: 30379361
[TBL] [Abstract][Full Text] [Related]
40. [Clinical-pharmacoeconomic aspects of trimetazidine modified release use in patients with ischemic heart disease undergoing coronary artery bypass grafting].
Lopatin IuM; Dronova EP
Kardiologiia; 2009; 49(2):15-21. PubMed ID: 19254211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
